Sagility Limited (NSE: SAGILITY) shares slipped in early trade on Wednesday after the company reported a strong set of third-quarter fiscal 2026 results. The stock was last quoted around ₹51.7, down modestly on the day, after recent strength from earlier earnings momentum. The share price remains within a 52-week range of ₹37.60 to ₹57.89.
Q3 FY26 Results
Sagility reported consolidated revenue of ₹19,712 million for the quarter ended Dec. 31, 2025, representing a 35.7% year-over-year increase (29.1% at constant currency). Organic revenue growth was 19.9% (13.9% in constant currency). Adjusted EBITDA was ₹5,125 million, with a margin of 26.0% and YoY growth of 24.2%. Adjusted profit after tax (PAT) rose 23.0% to ₹3,229 million, with a margin of 16.4%. Basic earnings per share were ₹0.57, up 23.9% YoY; adjusted basic EPS was ₹0.69, up 23.0% YoY.
For the nine months ended Dec. 31, 2025, revenue reached ₹51,686 million, up 29.2% YoY, while adjusted EBITDA and adjusted PAT increased 25.3% and 44.3% respectively, to ₹13,164 million and ₹8,236 million. Basic EPS for the period was ₹1.42, up 82.7%, and adjusted basic EPS was ₹1.76, up 41.7%.
Margins & Operational Metrics
Adjusted EBITDA margin held at 26.0% in Q3, broadly in line with prior quarters, as Sagility absorbed growth initiatives and scale benefits. Headcount at quarter-end was 48,522 across five countries supported by 35 delivery centres.
Market Context & Stock Performance
Sagility’s shares have seen heightened volatility over the past year, reflecting strong quarterly performance and broader market activity, with the stock trading up from its 52-week low near ₹37.6 to a high of ₹57.89.
Analyst Activity
Analyst coverage remains positive. Consensus estimates from multiple brokerages point to “Buy” ratings with an average 12-month price target near ₹65, implying upside from current levels. Some individual targets range above and below this average. There were no major analyst upgrades or downgrades directly linked to today’s results at the time of publication.
Outlook
Management highlighted strong operational execution during the open-enrolment period and continued momentum in the U.S. healthcare services market. Sagility also noted strategic recognitions in its investor materials.